Effectiveness of the XBB.1.5 COVID-19 vaccines against SARS-CoV-2 hospitalisation among adults aged ≥65 years during the BA.2.86/JN.1 predominant period, VEBIS hospital study, Europe, November 2023 to May 2024 | Publicación